Chengnan Huang, PhD, MS

Title(s)Postdoctoral Scholar, Anesthesia
SchoolSchool of Medicine
Address1001 Potrero Avenue, #163
San Francisco CA 94110
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tsinghua University, ChinaPhD06/2023Biology
    National Institute for Bioprocessing Research and Training, Ireland07/2017Glycoscience
    Wageningen University & Research, NetherlandsMS08/2017Pharmaceutical biotechnology
    China Agricultural University, ChinaBS06/2014Biotechnology

    Collapse Overview 
    Collapse Overview
    Antibody engineering and multi-specific antibody (drug conjugate) development for cancer therapy

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Quantifying Protein Shape to Elucidate Its Influence on Solution Viscosity in High-Concentration Electrolyte Solutions. Mol Pharm. 2024 Apr 01; 21(4):1719-1728. Tian Z, Jiang X, Chen Z, Huang C, Qian F. PMID: 38411904.
      View in: PubMed   Mentions:    Fields:    
    2. A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration. Bioeng Transl Med. 2024 Mar; 9(2):e10632. Huang C, Wang Y, Huang J, Liu H, Chen Z, Jiang Y, Chen Y, Qian F. PMID: 38435828; PMCID: PMC10905556.
      View in: PubMed   Mentions:
    3. Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration. Bioeng Transl Med. 2023 Nov; 8(6):e10523. Zhu S, Fan S, Tang T, Huang J, Zhou H, Huang C, Chen Y, Qian F. PMID: 38023710; PMCID: PMC10658565.
      View in: PubMed   Mentions:
    4. Multivalent nanobodies with rationally optimized linker and valency for intravitreal VEGF neutralization. Chemical Engineering Science. 2023; 270:118521. Huang C, Huang J, Zhu S, Tang T, Chen Y, Qian F. View Publication.
    5. Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection. Mol Pharm. 2022 May 02; 19(5):1505-1514. Huang C, Chen L, Franzen L, Anderski J, Qian F. PMID: 35417176.
      View in: PubMed   Mentions: 3     Fields:    
    6. Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro. Front Oncol. 2020; 10:1218. Greville G, Llop E, Huang C, Creagh-Flynn J, Pfister S, O'Flaherty R, Madden SF, Peracaula R, Rudd PM, McCann A, Saldova R. PMID: 32850359; PMCID: PMC7405916.
      View in: PubMed   Mentions: 13  
    Chengnan's Networks
    Concepts (7)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department